Instrument Inactif

Communiqués Abcam OTC Markets

Actions

ABCZF

GB00B6774699

Produits pharmaceutiques

Communiqués

06/12/23	Danaher Completes Acquisition of Abcam	PR
04/12/23	Acquisition of Abcam by Danaher Approved by the High Court of Justice of England and Wales	BU
17/11/23	Abcam Acquisition by Danaher Has Received All Identified Clearances; Transaction Expected to Close on December 6, 2023	BU
06/11/23	Shareholders of Abcam Approve Proposed Acquisition by Danaher	BU
01/11/23	Statement from Dr. Jonathan Milner on the suspension of the “Vote AGAINST” campaign	AQ
23/10/23	Leading Independent Proxy Advisor Glass Lewis Joins ISS in Recommending Shareholders Vote “FOR” Danaher Corporation’s Proposed Acquisition of Abcam	BU
17/10/23	Leading Proxy Advisor, ISS, Recommends Shareholders Vote “FOR” Danaher Corporation’s Proposed Acquisition of Abcam	BU
16/10/23	Jonathan Milner Issues Statement Responding to ISS Report	AQ
16/10/23	Jonathan Milner releases presentation to Abcam plc shareholders, outlining reasons to reject Danaher's bid and strategic vision for the Company	AQ
12/10/23	Independent Directors of Abcam Highlight Compelling Reasons for Shareholders to Support Proposed Sale to Danaher	BU
10/10/23	ABCAM INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Abcam plc - ABCM	BU
10/10/23	Jonathan Milner issues Open Letter to shareholders of Abcam plc	AQ
05/10/23	Abcam Files and Mails Scheme Circular Seeking Approval of Acquisition of Abcam by Danaher for $24.00 per Share	BU
28/09/23	Jonathan Milner issues Open Letter to shareholders of Abcam plc	AQ
15/09/23	Abcam plc Statement on Dr. Jonathan Milner’s Announcement	BU
14/09/23	Dr. Jonathan Milner opposes Danaher's acquisition of Abcam and calls for EGM to replace Board	AQ
01/09/23	Abcam plc - Interim results for the six-month period ended 30 June 2023	AQ
31/08/23	Abcam plc Interim Results for the Six-Month Period Ended 30 June 2023	BU
30/08/23	ABCAM INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Abcam plc - ABCM	BU
29/08/23	UK biotech firm Abcam snapped up by US medical giant for £4.5bn	AQ
28/08/23	Abcam : Transaction Agreement, dated as of August 26, 2023, by and between Danaher, the Purchaser and the Company - Form 6-K	PU
28/08/23	Danaher to acquire Abcam for $24.00 per Share	BU
28/08/23	Danaher to Acquire Abcam	PR
13/07/23	All Resolutions Withdrawn at Abcam's EGM	AQ
28/06/23	Abcam Confirms Dr. Jonathan Milner has Withdrawn EGM Requisition Notice and Related Resolutions	BU